Home

Jill Ann Howe

CIK 1892397 · Chief Financial Officer · last filed 2026-03-06

Jill Ann Howe is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LCTX, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$18.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $27.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.3K

Companies

3

Total Filings

12

Lifetime Open-Market Net

$18.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LCTX Chief Financial Officer 25,500 $1.07 $27.3K $18.2K 7 2026-03-06
BIORA THERAPEUTICS, INC. (BIOR) Delisted Director 3,192 $0.22 $702 $0 4 2024-06-06
BIORA THERAPEUTICS, INC. (PROG) Delisted Director 76,754 $0.88 $67.9K $0 1 2021-11-05

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-06 LCTX Grant (A) — $0 EDGAR
2025-03-12 LCTX Grant (A) — $0 EDGAR
2024-11-26 LCTX Buy (P) +15,000 $8.8K EDGAR
2024-08-19 LCTX Buy (P) +10,500 $9.3K EDGAR
2024-06-06 BIORA THERAPEUTICS, INC. (BIOR) Delisted Grant (A) +12,500 $0 EDGAR
2024-03-08 LCTX Grant (A) — $0 EDGAR
2023-06-16 BIORA THERAPEUTICS, INC. (BIOR) Delisted Grant (A) +12,500 $0 EDGAR
2023-03-10 LCTX Grant (A) — $0 EDGAR
2023-01-05 BIORA THERAPEUTICS, INC. (BIOR) Delisted Disp (D) −19 $0 EDGAR
2022-11-16 LCTX Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.